Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Enobosarm

QUALITY

Veru Inc · Phase 2 · Completed · Enrollment 168

NCT06282458

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Semaglutide and Enobosarm 3 mg QD by mouth (E3G) dailyn/rn/rn/rn/rn/r
Semaglutide and Enobosarm 6 mg QD by mouth (E6G) dailyn/rn/rn/rn/rn/r
GLP-1 receptor agonist and Placebo QD by mouth (PG) dailyn/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.